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SUMMARY 
Plasma creatine phosphokinase (GPK) was estimated from unmedicated schizophrenics to evaluate 
its significance in the diagnosis. The mean value of CPK in schizophrenics is 78.41±5.78 IU/L (n=49) as 
against control value of 27.45±2.27 IU/L (n = 36). The statistical analysis showed significance (p<0.05). 
The study finds its importance in view of the earlier reports suggesting the diagnostic value of C.P.K. 
Creatine phosphokinase is an enzyme 
which converts creatine phosphate to 
creatine and in turn releases the energy 
necessary for muscular action. CPK asso-
ciation has been demonstrated in muscular 
dystrophies, in particular to the Duchenne 
type, where it is elevated and has been one 
of the clinical parameters studied. The 
significance of CPK in schizophrenia was 
first suggested by Schiavone and Kaldore 
(1965). Subsequent studies on the subjects 
derived significant observations. No such 
study seems to be undertaken in Indian 
subjects. Hence the CPK estimations were 
undertaken in schizophrenia patients. 
MATERIALS AND METHODS 
49 schizophrenic patients from Hospital 
for Mental care Hyderabad, were chosen 
as subjects for the study. Cases were 
A diagnosed by a psychiatrist and care was 
taken to include unmedicated patients. 
Controls were selected from Institute staff. 
CPK was estimated by the method of 
Forter et al. (1974). 
RESULTS AND DISCUSSION 
The mean CPK values in schizophrenic 
patients and controls are shown in Table 
No. 1. 
The mean plasma CPK is found to be 
86.09 IU/L for schizophrenics as against 
< 30.905 IU/L in controls for males and 
TABLE 1 —Mean distribution of Plasma Creatine 
Phosphokinase activity in Schizophrenics and 
Control Groups 
Mean±S. E. 
N  IU/L 
Schizophrenic-Males 34 86.0-J-7.02 
Control Males .. 21 30.905±3.32 
Schizophrenic-
Females .. 15 63.06 ±9.3 
Control females .. 15 24.0 ±3.124 
Total Schizophrenics 49 78.41 ±5.78 
Controls ..36 27.45±2.27 
5.91* 
3.99* 
4.60* 
63.06 IU/L for schizophrenics as against 
24.0 IU/L in controls for females. The 
activity for total schizophrenics Vs controls 
is 78.4 IU/L and 27.45 IU/L respectively. 
The results are statistically significant (p< 
0.05.) 
The observations are in accordance 
with the findings of Meltzer (1969) and 
Meltzer et al., (1968, 1969) in a series of 
studies found elevations of CPK in 40-
65 % of psychotics. Meltzer estimated serum 
CPK from homozygote twins discordant for 
schizophrenia and suggested genetic control 
of CPK. But Cunningham et al. (1974) 
and Handing (1974) failed to confirm 
the findings of Meltzer and others. Handing 
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suggested that the raised levels reflect the 
increased motor activity and not the psy-
chotic illness. 
The etiological significance of elevated 
CPK in blood is still obscure and the rele-
vance of the elevation is yet to be studied. 
In a study, Meltzer and Engel (1970) 
have reported histological abnormalities such 
as 'Z' band spreadings in skeletal muscles 
from acute schizophrenics. They inter-
pret the alterations as secondary conse-
quences of an abnormality in nervous 
system factors (Meltzer and Crytous, 1974). 
It is still unknown whether histological 
differences are specific to schizophrenia. 
Thus owing to the above controversies 
about plasma CPK, our present study only 
confirms the elevated levels as reported by 
earlier workers, the significance of the 
elevation can be evaluated by undertaking 
the studies in the family members of the 
effected and the isozyme pattern studies 
of CPK. 
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